Role of the P2Y12 gene polymorphism in platelet responsiveness to clopidogrel in healthy subjects

被引：32

作者：

Bura, A.

Bachelot-Loza, C.

Ali, F. Dali

Aiach, M.

Gaussem, P.

机构：

[1] Hop Europeen Georges Pompidou, INSERM U 765, Serv Hematol Biol A, F-75908 Paris 15, France

[2] Hop Europeen Georges Pompidou, AP HP, F-75908 Paris 15, France

[3] Univ Paris 05, Paris, France

[4] INSERM, CIC 9201, Paris, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2006年 / 4卷 / 09期

关键词：

D O I：

10.1111/j.1538-7836.2006.02113.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2096 / 2097

页数：2

共 9 条

[1] Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases [J].

Aleil, B ;

Ravanat, C ;

Cazenave, JP ;

Rochoux, G ;

Heitz, A ;

Gachet, C .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) :85-92

[2] Aspirin and clopidogrel - Efficacy, safety, and the issue of drug resistance [J].

Cattaneo, M .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) :1980-1987

[3] P2Y12H2 haplotype is associated with peripheral arterial disease -: A case-control study [J].

Fontana, P ;

Gaussem, P ;

Aiach, M ;

Fiessinger, JN ;

Emmerich, J ;

Reny, JL .

CIRCULATION, 2003, 108 (24) :2971-2973

[4] Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects [J].

Fontana, P ;

Dupont, A ;

Gandrille, S ;

Bachelot-Loza, C ;

Reny, JL ;

Aiach, M ;

Gaussem, P .

CIRCULATION, 2003, 108 (08) :989-995

[5] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].

Gent, M ;

Beaumont, D ;

Blanchard, J ;

Bousser, MG ;

Coffman, J ;

Easton, JD ;

Hampton, JR ;

Harker, LA ;

Janzon, L ;

Kusmierek, JJE ;

Panak, E ;

Roberts, RS ;

Shannon, JS ;

Sicurella, J ;

Tognoni, G ;

Topol, EJ ;

Verstraete, M ;

Warlow, C .

LANCET, 1996, 348 (9038) :1329-1339

[6] Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction [J].

Matetzky, S ;

Shenkman, B ;

Guetta, V ;

Schechter, M ;

Bienart, R ;

Goldenberg, I ;

Novikov, I ;

Pres, H ;

Savion, N ;

Varon, D ;

Hod, H .

CIRCULATION, 2004, 109 (25) :3171-3175

[7] Resistance to clopidogrel: A review of the evidence [J].

Nguyen, TA ;

Diodati, JG ;

Pharand, C .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1157-1164

[8] Identification and biological activity of the active metabolite of clopidogrel [J].

Savi, P ;

Pereillo, JM ;

Uzabiaga, MF ;

Combalbert, J ;

Picard, C ;

Maffrand, JP ;

Pascal, M ;

Herbert, JM .

THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) :891-896

[9] Variability in platelet responsiveness to clopidogrel among 544 individuals [J].

Serebruany, VL ;

Steinhubl, SR ;

Berger, PB ;

Malinin, AI ;

Bhatt, DL ;

Topol, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (02) :246-251

← 1 →